FDA Inspection 1326286 — Stanford Blood Center, LLC

Stanford Blood Center, LLC — FEI 3005299783

The FDA completed an inspection of Stanford Blood Center, LLC on July 2, 2026 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 2, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Menlo Park, CA (United States)